Cuba’s Contribution to Combatting COVID-19 | WHAT REALLY HAPPENED

Cuba’s Contribution to Combatting COVID-19

COVID-19 surged in the Chinese city of Wuhan in late December 2019 and by January 2020 it had hit Hubei province like a tidal wave, swirling over China and rippling out overseas. The Chinese state rolled into action to combat the spread and care for those infected. Among the 30 medicines the Chinese National Health Commission selected to fight the virus was a Cuban anti-viral drug Interferon Alpha 2b. This drug has been produced in China since 2003, by the enterprise ChangHeber, a Cuban-Chinese joint venture.

Cuban Interferon Alpha 2b has proven effective for viruses with characteristics similar to those of COVID-19. Cuban biotech specialist, Dr Luis Herrera Martinez explained that ‘its use prevents aggravation and complications in patients, reaching that stage that ultimately can result in death.’ Cuba first developed and used interferons to arrest a deadly outbreak of the dengue virus in 1981, and the experience catalysed the development of the island’s now world-leading biotech industry.

Comments

SHARE THIS ARTICLE WITH YOUR SOCIAL MEDIA